These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 29597211

  • 1. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
    Tokunaga K, Yamagami H, Koga M, Todo K, Kimura K, Itabashi R, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Kario K, Yagita Y, Kitazono T, Kinoshita N, Takasugi J, Okata T, Yoshimura S, Sato S, Arihiro S, Toyoda K, SAMURAI Study Investigators.
    Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211
    [Abstract] [Full Text] [Related]

  • 2. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H.
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [Abstract] [Full Text] [Related]

  • 3. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
    Minematsu K, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.
    Cerebrovasc Dis; 2019 Jul; 48(1-2):53-60. PubMed ID: 31578012
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Jul; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Burden of Premature Atrial Complexes and Risk of Recurrent Stroke and Death in Patients with Mild to Moderate Ischemic Stroke.
    Sejr MH, May O, Damgaard D, Bruun NH, Nielsen JC.
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104490. PubMed ID: 31839547
    [Abstract] [Full Text] [Related]

  • 9. Pre-admission CHA2DS2-VASc score and outcome of patients with acute cerebrovascular events.
    Topaz G, Pereg D, Shuvy M, Mausbach S, Kimiagar I, Telman G, Kitay-Cohen Y, Vorobeichik D, Shlomo N, Tanne D.
    Int J Cardiol; 2017 Oct 01; 244():277-281. PubMed ID: 28645805
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
    Li S, Zhao X, Wang C, Liu L, Liu G, Wang Y, Wang C, Jing J, Wang YJ.
    J Stroke Cerebrovasc Dis; 2013 Nov 01; 22(8):e419-25. PubMed ID: 23721617
    [Abstract] [Full Text] [Related]

  • 11. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M, Fukuoka Stroke Registry Investigators.
    Cerebrovasc Dis; 2016 Nov 01; 42(3-4):196-204. PubMed ID: 27111222
    [Abstract] [Full Text] [Related]

  • 12. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T, Sato Y, Ozawa M, Kunugita F, Yoshizawa R, Morino Y, Nakamura M.
    Int Heart J; 2014 Nov 01; 55(2):119-25. PubMed ID: 24632957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemelä M, Lip GY, Airaksinen KE.
    Thromb Res; 2014 Apr 01; 133(4):560-6. PubMed ID: 24461143
    [Abstract] [Full Text] [Related]

  • 15. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, Savvari P, Manios E, Milionis H, Vemmos K.
    Neurology; 2013 Mar 12; 80(11):1009-17. PubMed ID: 23408865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.
    Yang YJ, Yuan JQ, Fan CM, Pu JL, Fang PH, Ma J, Guo XY, Li YS.
    Heart Vessels; 2016 Jul 12; 31(7):1148-53. PubMed ID: 26231425
    [Abstract] [Full Text] [Related]

  • 18. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
    Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB, APPROACH investigators.
    Heart; 2014 Oct 12; 100(19):1524-30. PubMed ID: 24860007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.